Institutional investors purchased a net $130.3 thousand shares of VICL during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 28.59% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Bought 427.00 shares of Vical Inc
FIRST BANK & TRUST (SIOUX FALLS,... Bought 50.00 shares of Vical Inc
METLIFE SECURITIES, INC. Sold 50.00 shares of Vical Inc